The fastest growing AI solution in the US market
Our Story

We are AEYE Health

A digital health company founded in 2019 in New York City with a singular
mission: help prevent blindness by making retinal screening accessible to
every patient, everywhere.

  • 2019
    Founded in NYC
  • FDA
    De Novo Cleared
  • #1
    Portable AI DR Solution
  • 45 +
    Team members
Our Mission

Combining AI expertise
with a passion for healthcare

Our founding members recognized the immense need to make screening for ocular diseases more accessible and identified the opportunity to address this need using AI technology. They embarked on a journey with the mission to help prevent blindness.

The highly accurate AI-based diagnostic screening solution developed by AEYE Health enables primary care providers to screen and diagnose patients on the spot — ensuring that patients, especially those in underserved communities that often go undiagnosed, can undergo critical sight-saving screening simply and swiftly.

The AEYE Health founding team
The People

The Leading Team

Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Danny Margalit
COO, Co-Founder

Co-Founder Aladdin (NASDAQ IPO).
Product & IP Expert

LinkedIn profile of Danny Margalit
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD
Zack Dvey-Aharon, PhD
CEO, Co-Founder

Serial entrepreneur, advisor, lecturer. Ph.D. in ML, 8200

LinkedIn profile of Zack Dvey-Aharon, PhD

Board Members

Yiannis Monovoukas,
PhD

Helios Global Investments.
CEO of TEI Biosciences,
acquired for $312M

Yiannis Monovoukas,
PhD

Helios Global Investments.
CEO of TEI Biosciences,
acquired for $312M

Yiannis Monovoukas,
PhD

Helios Global Investments.
CEO of TEI Biosciences,
acquired for $312M

Yiannis Monovoukas,
PhD

Helios Global Investments.
CEO of TEI Biosciences,
acquired for $312M

Medical Board

World-class ophthalmologists, endocrinologists, and clinical leaders guiding
our clinical standards.

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Sam Goldberger, MD
Medical Consultant

Ophthalmologist, CEO
Rangol Partners

Book a Demo